Press Release Service
Metagenomi Recognized as One of World’s Most...
Mar. 2, 2023
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Metagenomi
Main focus: Next-generation gene-editing systems
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: CRISPR-Cas9, multiple undisclosed
Funding stage: Private
Location: Everyville, CA, USA
Website: https://metagenomi.co/
Partners: Moderna, Vor Biopharma
Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. The company has yet not disclosed any of its lead programmes, but announced a multi-year, multi-target collaboration with Moderna to develop in vivo gene-editing therapeutics.
